Chen Yuanyuan, Yao Zhijian, Ruan Zhuren, Wei Gao, Zheng Wenjun, Li Xianghui
Department of Dermatology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Department of Dermatology, The First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road, Nanning, Guangxi 530021, China.
Ther Adv Infect Dis. 2025 Jun 14;12:20499361251333562. doi: 10.1177/20499361251333562. eCollection 2025 Jan-Dec.
The skin microbiota is crucial in defending against toxic, solar, and pathogenic assaults, yet it can also precipitate dermatosis when its equilibrium is disrupted. The composition and distribution of various microorganisms within the skin maintain a dynamic balance, modulating the barrier function and the immune system, thereby constituting the skin microbiota. This microbiota not only offers new insights into pathological microbe-host interactions and associated dermatoses but also inspires innovative therapeutic strategies that promise high efficacy and reduced symptomatology. In this review, we synthesize recent advancements in the field of skin microbiota, focusing on its relationship with dermatosis and the application of microbiota-based therapies in skin diseases. Our aim is to scrutinize the current understanding of the skin microbiota's role, ranging from a protective barrier to a causative agent of dermatosis.
皮肤微生物群在抵御毒性、日光和病原体侵袭方面至关重要,但当其平衡被打破时,也可能引发皮肤病。皮肤内各种微生物的组成和分布保持着动态平衡,调节着屏障功能和免疫系统,从而构成了皮肤微生物群。这种微生物群不仅为病理性微生物-宿主相互作用及相关皮肤病提供了新的见解,还启发了有望实现高效和减轻症状的创新治疗策略。在这篇综述中,我们综合了皮肤微生物群领域的最新进展,重点关注其与皮肤病的关系以及基于微生物群的疗法在皮肤疾病中的应用。我们的目的是审视目前对皮肤微生物群作用的理解,从保护屏障到皮肤病的致病因素。